Diamanti-Kandarakis E and Panidis D (2007) Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective ... they had biochemical or clinical hyperandrogenism, or no evidence ...

After treatment with this drug, the mice stopped showing symptoms of polycystic ovary syndrome. The team is now planning a clinical trial of cetrorelix in women with the condition, which they hope ...

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 6% of this population. [1] The clinical issues in PCOS relate to ...

Specifically, there was no evidence for polycystic ovaries ... proliferative endometrium without hyperplasia or neoplasia. The clinical and laboratory results were consistent with PCOS.

India: A recent pilot study has highlighted the potential benefits of yoga in improving insulin resistance among women with ...

Tired of bandaid solutions, doctors are expressing frustration with the lack of research and funding allotted to combatting the condition. Polycystic ovary syndrome is a common hormonal disorder ...

New research indicates that a natural compound found in the skin of grapes, blueberries and raspberries has the potential to ...

Women with polycystic ovary syndrome (PCOS) and obesity are at a ... said Professor Eszter Vanky at NTNU's Department of ...

The controlled ovarian hyperstimulation used before ... in the primary prevention of OHSS in patients with clinical risk factors, including polycystic ovaries or a previous history of OHSS.

Building on its commitment to women's health, Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a new ...